IDSIQ

Serial Number 79308218
Registration 6726798
700

Registration Progress

Application Filed
Dec 30, 2020
Under Examination
Approved for Publication
Mar 1, 2022
Published for Opposition
Mar 1, 2022
Registered
May 24, 2022

Trademark Image

IDSIQ

Basic Information

Serial Number
79308218
Registration Number
6726798
Filing Date
December 30, 2020
Registration Date
May 24, 2022
Published for Opposition
March 1, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
May 24, 2022
Registration
Registered
Classes
009 016 041 042

Rights Holder

Idorsia Pharmaceuticals Ltd

09
Address
Hegenheimermattweg 91
CH-4123 Allschwil
CH

Ownership History

Idorsia Pharmaceuticals Ltd

Original Applicant
09
CH

Idorsia Pharmaceuticals Ltd

Owner at Publication
09
CH

Idorsia Pharmaceuticals Ltd

Original Registrant
09
CH

Legal Representation

Attorney
Mary Margaret L. O'Donnell

USPTO Deadlines

Next Deadline
889 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20220524)
Due Date
May 24, 2028
Grace Period Ends
November 24, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description Documents
Oct 2, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 9, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 9, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
Aug 24, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
May 24, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 24, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 1, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 1, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 28, 2022 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Feb 9, 2022 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 9, 2022 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Feb 9, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 24, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 24, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 24, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 24, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jan 24, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 5, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 5, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 5, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 5, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 5, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 5, 2022 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jan 5, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 5, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 5, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 15, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 26, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jul 26, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 15, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jul 14, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 3, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 13, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 9, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 8, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 009
Downloadable electronic publications in the nature of newsletters and test results in the nature of test results documents and test result forms the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
First Use Anywhere: 0
First Use in Commerce: 0
Class 016
Printed matter in the nature of newsletters and brochures in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
First Use Anywhere: 0
First Use in Commerce: 0
Class 041
Multimedia publication of printed matter in the nature of newsletters, brochures, and test results in the nature of test results documents and test result forms in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; multimedia publication of printed matter in the nature of books, magazines and journals in the field of tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Scientific research and development, namely pharmaceutical testing and medical testing services not for diagnostic or treatment purposes and development of pharmaceutical and medical tests, all which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; scientific research, namely analysis of objective data on patients that was acquired by means of diagnostic tests in the context of drug administration, analysis of subjective data on patients that was acquired by means of patient questioning, analysis of such data with the aim of optimizing drug treatments and drug administration
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
009 016 041 042